Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3927-3932

  Auliff, Alyson M ^a,b   Adams, John H ^c   O'Neil, Michael T ^d   Cheng, Qin ^a  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; CYCLOGUANIL; DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; PYRIMETHAMINE; THYMIDYLATE SYNTHASE;

ARTICLE; CLINICAL EVALUATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; NULL ALLELE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTOZOAL GENETICS;

ANIMALS; FOLIC ACID ANTAGONISTS; MULTIENZYME COMPLEXES; MUTATION; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE; TRANSFECTION;

EID: 77956097961     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00628-10     Document Type: Article

References (45)

1. Alam, M. T., H. Bora, P. K. Bharti, M. A. Saifi, M. K. Das, V. Dev, A. Kumar, N. Singh, A. P. Dash, B. Das, and Y. D. Wajihullah Sharma. 2007. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents Chemother. 51:857-863.
2. Auliff, A., D. W. Wilson, B. Russell, Q. Gao, N. Chen, N. Anh le, J. Maguire, D. Bell, M. T. O'Neil, and Q. Cheng. 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am. J. Trop. Med. Hyg. 75:617-621.
3. Brega, S., F. de Monbrison, C. Severini, R. Udomsangpetch, I. Sutanto, P. Ruckert, F. Peyron, and S. Picot. 2004. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob. Agents Chemother. 48:2581-2587.
4. Bzik, D. J., W. B. Li, T. Horii, and J. Inselburg. 1987. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc. Natl. Acad. Sci. U. S. A. 84:8360-8364.
5. Chen, G. X., C. Mueller, M. Wendlinger, and J. W. Zolg. 1987. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine- sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Mol. Pharmacol. 31:430-437.
6. Chen, N., A. Auliff, K. Rieckmann, M. Gatton, and Q. Cheng. 2007. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195:934-941.
7. Coatney, G. R. 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am. J. Trop. Med. Hyg. 12:121-128.
8. Cowman, A. F., M. J. Morry, B. A. Biggs, G. A. Cross, and S. J. Foote. 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 85:9109-9113.
9. Darlow, B., H. Vrbova, S. Gibney, D. Jolley, J. Stace, and M. Alpers. 1982. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax. Am. J. Trop. Med. Hyg. 31:10-13. (Pubitemid 12179892)
10. Deitsch, K., C. Driskill, and T. Wellems. 2001. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 29:850-853. (Pubitemid 32124398)
11. de Pecoulas, P. E., L. K. Basco, R. Tahar, T. Ouatas, and A. Mazabraud. 1998. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene 211:177-185.
12. de Pecoulas, P. E., R. Tahar, T. Ouatas, A. Mazabraud, and L. K. Basco. 1998. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol. Biochem. Parasitol. 92:267-273.
13. Doberstyn, E. B., C. Teerakiartkamjorn, R. G. Andre, P. Phintuyothin, and S. Noeypatimanondh. 1979. Treatment of vivax malaria with sulfadoxinepyrimethamine and with pyrimethamine alone. Trans. R. Soc. Trop. Med. Hyg. 73:15-17.
14. Edstein, M. D., S. Bahr, B. Kotecka, G. D. Shanks, and K. H. Rieckmann. 1997. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand. Antimicrob. Agents Chemother. 41:2300-2301.
15. Foote, S. J., D. Galatis, and A. F. Cowman. 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. U. S. A. 87:3014-3017.
16. Garnham, P. C. 1988. Swellengrebel lecture: hypnozoites and "relapses" in Plasmodium vivax and in vivax-like malaria. Trop. Geogr. Med. 40:187-195.
17. Hastings, M. D., J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley. 2005. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. Antimicrob. Agents Chemother. 49:733-740.
18. Hastings, M. D., K. M. Porter, J. D. Maguire, I. Susanti, W. Kania, M. J. Bangs, C. H. Sibley, and J. K. Baird. 2004. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J. Infect. Dis. 189:744-750.
19. Hastings, M. D., and C. H. Sibley. 2002. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proc. Natl. Acad. Sci. U. S. A. 99:13137-13141.
20. Imwong, M., S. Pukrittakayamee, S. Looareesuwan, G. Pasvol, J. Poirreiz, N. J. White, and G. Snounou. 2001. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45:3122-3127.
21. Imwong, M., S. Pukrittayakamee, L. Renia, F. Letourneur, J. P. Charlieu, U. Leartsakulpanich, S. S. Looareesuwan, N. J. White, and G. Snounou. 2003. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob. Agents Chemother. 47:1514-1520.
22. Kitchener, S. J., A. M. Auliff, and K. H. Rieckmann. 2000. Malaria in the Australian Defence Force during and after participation in the International Force in East Timor (INTERFET). Med. J. Aust. 173:583-585.
23. Kongsaeree, P., P. Khongsuk, U. Leartsakulpanich, P. Chitnumsub, B. Tarnchompoo, M. D. Walkinshaw, and Y. Yuthavong. 2005. Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance. Proc. Natl. Acad. Sci. U. S. A. 102:13046-13051.
24. Leartsakulpanich, U., M. Imwong, S. Pukrittayakamee, N. J. White, G. Snounou, W. Sirawaraporn, and Y. Yuthavong. 2002. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol. Biochem. Parasitol. 119:63-73.
25. Mendis, K., B. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
26. Oduola, A. M., A. Sowunmi, W. K. Milhous, T. G. Brewer, D. E. Kyle, L. Gerena, R. N. Rossan, L. A. Salako, and B. G. Schuster. 1998. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. Am. J. Trop. Med. Hyg. 58:625-629.
27. Oduola, A. M., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1988. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp. Parasitol. 66:86-95.
28. O'Neil, M. T., M. L. Korsinczky, K. J. Gresty, A. Auliff, and Q. Cheng. 2007. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase. J. Infect. Dis. 196:467-474.
29. Peters, W. 1998. Drug resistance in malaria parasites of animals and man. Adv. Parasitol. 41:1-61.
30. Peterson, D. S., D. Walliker, and T. E. Wellems. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U. S. A. 85:9114-9118.
31. Pukrittayakamee, S., A. Chantra, J. A. Simpson, S. Vanijanonta, R. Clemens, S. Looareesuwan, and N. J. White. 2000. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44:1680-1685.
32. Sirawaraporn, W., P. Prapunwattana, R. Sirawaraporn, Y. Yuthavong, and D. V. Santi. 1993. The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase: gene synthesis, expression, and anti-folate-resistant mutants. J. Biol. Chem. 268:21637-21644.
33. Sirawaraporn, W., R. Sirawaraporn, A. F. Cowman, Y. Yuthavong, and D. V. Santi. 1990. Heterologous expression of active thymidylate synthase- dihydrofolate reductase from Plasmodium falciparum. Biochemistry 29:10779-10785.
34. Sirawaraporn, W., S. Yongkiettrakul, R. Sirawaraporn, Y. Yuthavong, and D. V. Santi. 1997. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant. Exp. Parasitol. 87:245-252.
35. Sirawaraporn, W., and Y. Yuthavong. 1984. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine- resistant Plasmodium chabaudi. Mol. Biochem. Parasitol. 10: 355-367.
36. Snewin, V. A., S. M. England, P. F. Sims, and J. E. Hyde. 1989. Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine. Gene 76:41-52.
37. Suwanarusk, R., B. Russell, M. Chavchich, F. Chalfein, E. Kenangalem, V. Kosaisavee, B. Prasetyorini, K. A. Piera, M. Barends, A. Brockman, U. Lek-Uthai, N. M. Anstey, E. Tjitra, F. Nosten, Q. Cheng, and R. N. Price. 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One 2:e1089.
38. Tahar, R., P. E. de Pecoulas, L. K. Basco, M. Chiadmi, and A. Mazabraud. 2001. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Mol. Biochem. Parasitol. 113:241-249.
39. Tjitra, E., J. Baker, S. Suprianto, Q. Cheng, and N. M. Anstey. 2002. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine- sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob. Agents Chemother. 46: 3947-3953.
40. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. J. Parasitol. 91:484-486.
41. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776.
42. Young, M. D., and R. W. Burgess. 1959. Pyrimethamine resistance in Plasmodium vivax malaria. Bull. World Health Organ. 20:27-36.
43. Zhang, K., and P. K. Rathod. 2002. Divergent regulation of dihydrofolate reductase between malaria parasite and human host. Science 296:545-547.
44. Zolg, J. W., G. X. Chen, and J. R. Plitt. 1990. Detection of pyrimethamine resistance in Plasmodium falciparum by mutation-specific polymerase chain reaction. Mol. Biochem. Parasitol. 39:257-265.
45. Zolg, J. W., J. R. Plitt, G. X. Chen, and S. Palmer. 1989. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 36:253-262.